Lamotrigine Tablet
Product Images NDC 69918-360

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 69918-360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nordic Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Pack (Lamotrigine 100mg)

Label for Lamotrigine Orally Disintegrating Tablets, USP 100 mg by Nordic Pharma, Inc. The label includes dosage and storage instructions, caution for pharmacists to dispense a medication guide, details for phenylketonurics, and a 30-tablet count. The label features barcodes and manufacturing information from AMRI Pharmaceuticals LLC.*

FDA Label Image

30's Bottle Pack (Lamotrigine 200mg)

Label for Lamotrigine Orally Disintegrating Tablets, USP, 200 mg strength, produced by Nordic Pharma, Inc. The label includes dosage instructions, storage conditions, a caution to verify the product dispensed, and a note for pharmacists to provide the medication guide to patients. The package contains 30 tablets and features barcodes and manufacturer details.*

FDA Label Image

30's Bottle Pack (Lamotrigine 25)

Label for Lamotrigine 25 mg orally disintegrating tablets, USP, manufactured by Nordic Pharma, Inc. The label includes NDC 69918-350-30, highlights that it is for oral use and prescription only, and contains 30 tablets. It features storage instructions, dosage cautions, and a pharmacist warning to dispense a medication guide. The label also notes the phenylalanine content and cautions against use if the safety seal is broken or missing.*

FDA Label Image

30's Bottle Pack (Lamotrigine 50mg)

Label for Lamotrigine Orally Disintegrating Tablets, USP 50 mg, containing 30 tablets. Manufactured by Amring Pharmaceuticals Inc. under labeler Nordic Pharma, Inc. The label includes dosage instructions, storage information at 20° to 25°C, and warnings for child-resistant packaging and phenylalanine content. It features the NDC 69918-360-30 and a barcode, with a note of no varnish on the label.*

FDA Label Image

Figure 1 (Lamotrigine Figure1)

A line graph showing failure probability (%) over weeks comparing Lamotrigine Tablets with Placebo. The x-axis represents weeks up to 100, and the y-axis shows failure probability from 0 to 100%. Two curves are plotted, with Placebo having a higher failure probability than Lamotrigine Tablets over time. Censored data points are marked on the graph.*

FDA Label Image

Figure 2 (Lamotrigine Figure2)

A line graph comparing failure probability (%) over weeks between Placebo and Lamotrigine Tablets. The x-axis represents weeks up to 80, and the y-axis shows failure probability up to 100%. Censored data points are marked. The Placebo line shows higher failure probability than the Lamotrigine Tablets line over time.*

FDA Label Image

Tabs 25 mg (Lamotrigine Graphic)

This image is a text panel that describes the imprint, color, and dosage strength of Lamotrigine tablets. It covers four tablets: 25 mg tablet is white to off-white with 'AC' on one side and '159' on the other; 50 mg tablet is white to off-white with 'AC 160' on one side and plain on the other; 100 mg tablet is white to off-white with 'AC 161' on one side and plain on the other; 200 mg tablet is white to off-white with 'AC 162' on one side and plain on the other.*

FDA Label Image

Label (Lamotrigine Label)

FDA Label Image

Structure (Lamotrigine Str)

Chemical structure of Lamotrigine showing its molecular configuration with chlorine and nitrogen atoms as part of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.